This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: University of Florida Research Foundation Inc., University of Pennsylvania. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3,052 
2 out of 2,659 
Years Active: 2017-2019
Title: Innovations in Gene Therapy: The Contributions of Wen-Tao Deng
Introduction
Wen-Tao Deng is a prominent inventor based in Gainesville, FL (US), known for her significant contributions to the field of gene therapy. With a focus on retinal degeneration, she has developed innovative methods aimed at preventing vision loss associated with retinitis pigmentosa. Her work has led to the filing of 2 patents, showcasing her commitment to advancing medical science.
Latest Patents
One of her latest patents is centered around AAV-mediated gene therapy for RPGR X-linked retinal degeneration. This patent describes methods for preventing, arresting progression, or ameliorating vision loss and other conditions related to retinitis pigmentosa and X-linked retinitis pigmentosa. The methods involve administering an effective concentration of a composition that includes a recombinant adeno-associated virus (AAV) carrying a nucleic acid sequence encoding a normal retinitis pigmentosa GTPase regulator (RPGR gene). This gene is expressed in the photoreceptor cells of the subject, along with a pharmaceutically acceptable carrier.
Career Highlights
Wen-Tao Deng has worked with esteemed institutions such as the University of Florida Research Foundation Inc. and the University of Pennsylvania. Her career reflects a dedication to research and innovation in the field of gene therapy, particularly in addressing genetic disorders affecting vision.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Gustavo D Aguirre and Samuel Jacobson. These partnerships have further enriched her research and contributed to the advancement of gene therapy techniques.
Conclusion
Wen-Tao Deng's work in gene therapy represents a significant advancement in the treatment of retinal degeneration. Her innovative approaches and collaborations highlight her role as a leading inventor in this critical area of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile